Identification of an Enhancer Sequence within the First Intron Required for Cartilage-specific Transcription of the α2(XI) Collagen Gene*

Type XI collagen, a heterotrimer composed of α1(XI), α2(XI) and α3(XI), is primarily synthesized by chondrocytes in cartilage and is also present in some other tissues. Type XI collagen plays a critical role in collagen fibril formation and skeletal morphogenesis. We investigated a tissue-specific transcriptional enhancer in the first intron of the α2(XI) collagen gene (Col11a2). Transient transfection assays using reporter gene constructs revealed that a 60-base pair (bp) segment within intron 1 increased promoter activity of Col11a2 in rat chondrosarcoma cells but not in either BalB/3T3 cells or undifferentiated ATDC5 cells, suggesting that it contained cell type-specific enhancer activity. In transgenic mice, this 60-bp fragment was also able to target β-galactosidase expression to cartilage including the limbs and axial skeleton, with similar localization specificity as the full-length intron 1 fragment. Competition experiments in gel shift assays using mutated oligonucleotides showed that recombinant Sox9 bound to a 7-bp sequence, CTCAAAG, within the 60-bp segment. Anti-Sox9 antibodies supershifted the complex of the 60-bp segment with recombinant Sox9 or with rat chondrosarcoma cell extracts, confirming the binding of Sox9 to the enhancer. Moreover, a site-specific mutation within the 7-bp segment resulted in essentially complete loss of the enhancer activity in chondrosarcoma cells and transgenic mice. These results suggest that the 7-bp sequence within intron 1 plays a critical role in the cartilage-specific enhancer activity of Col11a2 through Sox9-mediated transcriptional activation.

[1]  N. Morris,et al.  A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesis , 1995, Cell.

[2]  A Farr,et al.  A pitfall of using a second plasmid to determine transfection efficiency. , 1992, Nucleic acids research.

[3]  B. Hogan,et al.  Manipulating the mouse embryo: A laboratory manual , 1986 .

[4]  Andy Greenfield,et al.  The Sry-related gene Sox9 is expressed during chondrogenesis in mouse embryos , 1995, Nature Genetics.

[5]  T. Atsumi,et al.  Chondrogenic differentiation of clonal mouse embryonic cell line ATDC5 in vitro: differentiation-dependent gene expression of parathyroid hormone (PTH)/PTH-related peptide receptor , 1996, The Journal of cell biology.

[6]  T. Kimura,et al.  Differential Expression of an Acidic Domain in the Amino-terminal Propeptide of Mouse Pro-2(XI) Collagen by Complex Alternative Splicing (*) , 1995, The Journal of Biological Chemistry.

[7]  Y. Yamada,et al.  A Compilation of Partial Sequences of Randomly Selected cDNA Clones from the Rat Incisor , 1995, Journal of dental research.

[8]  V. Lefebvre,et al.  Chondrocyte-specific Enhancer Elements in the Col11a2Gene Resemble the Col2a1 Tissue-specific Enhancer* , 1998, The Journal of Biological Chemistry.

[9]  T. Ochi,et al.  Separable cis-regulatory elements that contribute to tissue- and site- specific alpha 2(XI) collagen gene expression in the embryonic mouse cartilage , 1996, The Journal of cell biology.

[10]  K. Cheah,et al.  Autosomal dominant and recessive osteochondrodysplasias associated with the COL11A2 locus , 1995, Cell.

[11]  D. Eyre,et al.  Cartilage type IX collagen is cross-linked by hydroxypyridinium residues. , 1984, Biochemical and biophysical research communications.

[12]  B. Olsen,et al.  The human alpha 2(XI) collagen (COL11A2) chain. Molecular cloning of cDNA and genomic DNA reveals characteristics of a fibrillar collagen with differences in genomic organization. , 1989, The Journal of biological chemistry.

[13]  E. J. Miller,et al.  Different levels of glycosylation contribute to the heterogeneity of alpha 1(II) collagen chains derived from a transplantable rat chondrosarcoma. , 1983, Archives of biochemistry and biophysics.

[14]  Gerd Scherer,et al.  Sex reversal by loss of the C–terminal transactivation domain of human SOX9 , 1996, Nature Genetics.

[15]  L. Vaughan,et al.  Cartilage contains mixed fibrils of collagen types II, IX, and XI , 1989, The Journal of cell biology.

[16]  Sahar Mansour,et al.  Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene , 1994, Nature.

[17]  K. Cheah,et al.  Expression of the mouse alpha 1(II) collagen gene is not restricted to cartilage during development. , 1991, Development.

[18]  K. Brandt,et al.  Interaction of proteoglycans with the pericellular (1 alpha, 2 alpha, 3 alpha) collagens of cartilage. , 1985, The Journal of biological chemistry.

[19]  T. Ochi,et al.  Differential in situ expression of α2(XI) collagen mRNA isoforms in the developing mouse , 1998, Cell and Tissue Research.

[20]  L. Vaughan,et al.  D-periodic distribution of collagen type IX along cartilage fibrils , 1988, The Journal of cell biology.

[21]  K. Kuettner,et al.  Biochemistry of articular cartilage in health and disease. , 1992, Clinical biochemistry.

[22]  Y. Liu,et al.  Overexpression of a Single Helix-Loop-Helix-type Transcription Factor, Scleraxis, Enhances Aggrecan Gene Expression in Osteoblastic Osteosarcoma ROS17/2.8 Cells* , 1997, The Journal of Biological Chemistry.

[23]  B. Crombrugghe,et al.  Toward understanding SOX9 function in chondrocyte differentiation. , 1998 .

[24]  G. Kopen,et al.  A 1,064 bp fragment from the promoter region of the Col11a2 gene drives lacZ expression not only in cartilage but also in osteoblasts adjacent to regions undergoing both endochondral and intramembranous ossification in mouse embryos. , 1998, Matrix biology : journal of the International Society for Matrix Biology.

[25]  R. Roeder,et al.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. , 1983, Nucleic acids research.

[26]  V. Lefebvre,et al.  Use of a New Rat Chondrosarcoma Cell line to Delineate a 119-Base Pair Chondrocyte-specific Enhancer Element and to Define Active Promoter Segments in the Mouse Pro-α1(II) Collagen Gene (*) , 1995, The Journal of Biological Chemistry.

[27]  P N Goodfellow,et al.  DNA binding activity of recombinant SRY from normal males and XY females. , 1992, Science.

[28]  Donald M. Bell,et al.  SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse. , 1997, Developmental biology.

[29]  B. Olsen,et al.  Cloning and sequencing of pro-alpha 1 (XI) collagen cDNA demonstrates that type XI belongs to the fibrillar class of collagens and reveals that the expression of the gene is not restricted to cartilagenous tissue. , 1988, The Journal of biological chemistry.

[30]  P N Goodfellow,et al.  SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene , 1997, Molecular and cellular biology.

[31]  N. Morris,et al.  Ultrastructural localization of collagen types II, IX, and XI in the growth plate of human rib and fetal bovine epiphyseal cartilage: type XI collagen is restricted to thin fibrils. , 1995, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[32]  Patrick P.L. Tam,et al.  SOX9 directly regulates the type-ll collagen gene , 1997, Nature Genetics.

[33]  T. Ochi,et al.  Modular Arrangement of Cartilage- and Neural Tissue-specificcis-Elements in the Mouse α2(XI) Collagen Promoter* , 1998, The Journal of Biological Chemistry.

[34]  N. Tommerup,et al.  Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9 , 1994, Cell.

[35]  Véronique Lefebvre,et al.  A new long form of Sox5 (L‐Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene , 1998, The EMBO journal.